What is it about?
Cost of chemotherapeutic agents compared form a community generic outlet and brads available in India for the treatment of Breast Cancer. This work provides an insight in to cost sensitive Indian market for chemotherapy.
Photo by Allie Smith on Unsplash
Why is it important?
This work provides insights that, substituting available generic chemotherapeutic drugs can bring a potential cost savings, reducing out of pocket expenditure and can make every patient to adhere to medications without restriction of economic crisis. Thus will help healthcare professionals to take informed decisions while treating patients with Breast Cancer. It also serves as a reckoner for policy makers to take policy decisions for public spending.
Read the Original
This page is a summary of: Cost analysis of various branded versus generic chemotherapeutic agents used for the treatment of early breast cancer- a deep insight from India, Expert Review of Pharmacoeconomics & Outcomes Research, July 2019, Taylor & Francis, DOI: 10.1080/14737167.2019.1637735.
You can read the full text:
The following have contributed to this page